Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense ...
B-cell lymphoma accounts for approximately 85 percent ... in ensuring accurate and timely diagnosis, especially as the symptoms can appear similar," said Jill German, Head of Pathology Lab at ...
The following is a summary of “Limited Benefit of Routine Clinical Follow-Up for Relapse Detection in Diffuse Large B-Cell ...
The new first-line MCL indication gives Calquence a slice of the market of its own and could spur further growth of the drug, ...
During a Case-Based Roundtable® event, Jean A. Yared, MD, moderated a discussion on the approach to CAR T-cell therapy for a ...
Immune complexes, like the inflammasome, help protect stem cells from cancer by removing surface receptors and suppressing ...
AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma: Cambridge, UK Monday, January 20, 2025, 09:00 Hrs [IS ...
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...